Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 686 | Thu, 8/8/2013, 10:30 AM - 12:20 PM | CC-511c | |
| Statistical Methods for Adaptive Designs — Contributed Papers | |||
| Biopharmaceutical Section , Biometrics Section | |||
| Chair(s): Olga Marchenko, Quintiles | |||
| 10:35 AM | Adaptive Designs for Dose-Ranging Studies Based on Group-Sequential Methods — Yevgen Tymofyeyev, Janssen RD of J&J ; Jose Carlos Pinheiro, Janssen R&D | ||
| 10:50 AM | Stage-Wise Optimal Adaptive Dose Study Design — Gang Jia, Merck & Co. | ||
| 11:05 AM | Futility Analysis in a Phase II Clinical Trial — Bo Jin, Pfizer Inc. | ||
| 11:20 AM | Strategies Considered in Designing an FTIH Trial — Yu Lou, GlaxoSmithKline ; Jianjun Gan, GlaxoSmithKline | ||
| 11:35 AM | Seamless Phase IIa/IIb and Enhanced Dose Finding Adaptive Design — Jiacheng Yuan, Novartis ; Herbert Pang, DU School of Medicine ; Tiejun Tong, Hong Kong Baptist University | ||
| 11:50 AM | Optimal Timing for Interim Analysis in Phase 2 Drug Development: A Real Options Approach — Ouhong Wang, Amgen | ||
| 12:05 PM | Multi-Stage Clinical Trial Design with Multidimensional Mixed Endpoints — Peng Huang, Johns Hopkins University - Oncology Biostatistics ; Ming Tan, Georgetown University Medical Center | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.